Afatinib vs gemcitabine/cisplatin for advanced NSCLCin Chinese patients - Video Abstract ID 160358

Video abstract of original research “ Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial” published in the open access journal OncoTargets and Therapy by authors Wu YL, Xu CR, Hu CP, et al. Read the original research paper here: https://www.dovepress.com/afatinib-versus-gemcitabinecisplatin-for-first-line-treatment-of-chine-peer-reviewed-article-OTT